Quantum convoy covers 1,000 miles for cancer

Pharmaceutical specials manufacturer raises £5,000 for charity

Ten amateur cyclists from pharmaceutical manufacturer Quantum Pharmaceutical have completed a 1,000-mile charity bike ride to raise £5,000 for Marie Curie Cancer Care.

The team signed up for the challenge after their colleague Tony Gallagher died of cancer in 2008.

Gallagher’s son, Scott, led the cycle convoy, which rode off from Land’s End in Cornwall and cycled up to 90 miles a day to cross the finishing line at John O’Groats in Caithness, Scotland a fortnight later.

‘It was a testing couple of weeks,’ said Quantum Pharmaceutical’s managing director Andy Scaife.

‘We remember Tony so fondly, and cycling a thousand miles will be nothing compared with the challenge he faced in fighting cancer. We just hope the money we raise will help other cancer sufferers as they battle with the disease.’

Quantum Pharmaceutical, based in Burnopfield, Co Durham, UK, is a pharmaceutical specials manufacturer licensed by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to supply pharmacies, chemists, dispensing doctors and hospitals with bespoke medicines.

You may also like

Regulatory

Penn Pharma recalls batches of seizure drug

Following incorrect placement of screw caps on some units of Midazolam buccal liquid, which could affect drug concentration
Containment

Quantum Pharmaceutical opens aseptic manufacturing facility

Incorporates aseptic compounding and manufacturing services, including gassing isolators
Manufacturing

Quantum Pharmaceutical moves into new HQ

Opens up potential for further expansion of the UK specials manufacturer
Manufacturing

Bracco enters cell therapy manufacturing with microbubble-based cell selection technology

Bracco Imaging is expanding into cell therapy manufacturing with a bead-free cell selection and activation technology based on its clinically validated microbubble platform
Medical Devices

Biocomposites gains MDR certification for STIMULAN antibiotic carriers

Biocomposites has secured EU MDR certification for its STIMULAN Rapid Cure and STIMULAN Kit products, enabling them to be mixed with multiple Gram-positive and Gram-negative antibiotics for infection management in bone and soft tissue
Pharma 5.0

New computational approaches could pave the way for safer medicines with fewer side effects

Advances in computational modelling and artificial intelligence are offering new ways to understand why medicines cause side effects and how to avoid them in future drug development
Digital

Shimadzu introduces a new site for its portfolio of LIB solutions

The website especially targets battery cell manufacturers, e-vehicle OEMs, research institutions as well as recycling companies and start-ups. There they will find Shimadzu’s latest solutions in the LIB market, including in-depth background information such as brochures and FAQs as well as featured highlight products
Subscribe now